Expression and significance of PCNA and p27 in benign prostate hypertrophy and prostate carcinoma / 中华肿瘤杂志
Chinese Journal of Oncology
; (12): 476-478, 2004.
Article
de Zh
| WPRIM
| ID: wpr-254290
Bibliothèque responsable:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the expression of PCNA and p27 in human benign prostate hypertrophy (BPH) and prostate carcinoma (PCa) and their effect on the genesis and progression of the tumor.</p><p><b>METHODS</b>The paraffin-embedded sections of 30 cases with BPH and 37 cases with PCa were collected. The expression of p27 and PCNA protein were examined by S-P immunohistochemical method. Comparative analysis for BPH and pathological grade and clinical stage of PCa was performed.</p><p><b>RESULTS</b>The expression of PCNA in BPH (3.3%) was significantly lower than that in Pca (83.8%, P < 0.01). The expression of p27 in BPH (70.0%) was significantly higher than that in Pca (27.0%, P < 0.05). The expression of p27 was not correlated with histological grade and clinical stage in Pca (P > 0.05). An inverse correlation was found between p27 and PCNA expression in BPH (P < 0.01), while no correlation was found in Pca (P > 0.05).</p><p><b>CONCLUSION</b>The loss or decreased expression of p27 protein may be related to the genesis of benign prostate hypertrophy, but not to the development of prostate carcinoma; the overexpression of PCNA may play an important role in the malignant behavior and progression of prostate carcinoma.</p>
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Anatomopathologie
/
Pronostic
/
Hyperplasie de la prostate
/
Tumeurs de la prostate
/
Adénocarcinome
/
Régulation de l'expression des gènes tumoraux
/
Gènes suppresseurs de tumeur
/
Antigène nucléaire de prolifération cellulaire
/
Protéines du cycle cellulaire
/
Protéines suppresseurs de tumeurs
Type d'étude:
Prognostic_studies
Limites du sujet:
Aged
/
Aged80
/
Humans
/
Male
langue:
Zh
Texte intégral:
Chinese Journal of Oncology
Année:
2004
Type:
Article